CNBC
US · 43 mins ago
Abivax $920 million cash haul lets it prepare for solo U.S. launch instead of relying on a buyer, CEO tells CNBC
Its latest fundraising round provides the French biotech with enough cash to finance operations through 2029.
Do you trust CNBC?
Sign in to rate
Discussion 0 comments
Sort:
?
No comments yet — be the first to start the discussion!